Hormone treatment for overactive bladder and mood symptoms
Treatments studied
Part of Heart & circulation, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This trial studies whether hormone treatment can improve overactive bladder symptoms, sexual well-being, mood (depressive symptoms), and body “autonomic” function (automatic body functions like heart rate and sweating) in post-menopausal women. It may help by targeting menopausal changes that can affect these symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman and older than 20 years
- You should have menopausal symptoms
- You must still have your uterus
- You must not have breast cancer or other cancers
- You must not have a history of major blocked blood-vessel problems (like stroke)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether hormone treatment can help prevent or slow Alzheimer’s disease in women who have gone through menopause. It may help by testing a hormone-based approach in a carefully selected group.
This study compares two types of hormone therapy for menopause symptoms: one is a pill taken by mouth (dydrogesterone), and the other is a vaginal gel or suppository (progesterone). The goal is to see which one works better and is safer, so you and your doctor can choose the best option.
This study looks at how menopausal hormone therapy affects the brain and heart during menopause. It aims to see if starting hormone therapy can help improve heart and brain health in women with bothersome hot flashes.
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
This study tests two devices (BTL-699-2 and HPM-6000UF) to see if they can improve depression symptoms and sexual function in women going through menopause or perimenopause. It may help with mood and intimacy during this life stage.
This Phase 3 study compares two types of progesterone—micronized progesterone versus norethisterone acetate—both used with estrogen to treat menopause symptoms that affect daily life. It aims to see which combination works better and is tolerated over time for women with an intact uterus.
Hear when a new Menopausal Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.